Prevalence of antimicrobial-resistant organisms in smaller Canadian hospitals: Community, Rural, and Northern Acute Care Point Prevalence (CNAPP-19) Survey, 2019.

Clostridioides difficile infection Escherichia coli antimicrobial resistance antimicrobial resistant organisms carbapenemase-producing Enterobacterales methicillin-resistant Staphylococcus aureus nosocomial infections point prevalence study vancomycin-resistant Enterococci

Journal

Canada communicable disease report = Releve des maladies transmissibles au Canada
ISSN: 1188-4169
Titre abrégé: Can Commun Dis Rep
Pays: Canada
ID NLM: 9303729

Informations de publication

Date de publication:
03 Nov 2022
Historique:
medline: 3 11 2022
pubmed: 3 11 2022
entrez: 15 1 2024
Statut: epublish

Résumé

The availability of national data on the prevalence of antimicrobial resistant infections in smaller, community, northern and rural acute care hospitals is limited. The objective of this article is to determine the prevalence of infections caused by selected antimicrobial-resistant organisms (AROs) in these smaller hospitals. A point prevalence survey was conducted by 55 hospitals between February and May 2019 and included representation from all 10 Canadian provinces. Eligible hospitals were those with 350 or fewer beds. Data were collected on hospital characteristics. De-identified patient data were collected on selected infections (pneumonia, urinary tract infections, bloodstream infections, skin/soft tissue infections, surgical site infections, and A total of 3,640 patients were included in the survey. Median patient age was 73 years, and 52.8% (n=1,925) were female. Selected infections were reported in 14.4% (n=524) of patients, of which 6.9% (n=36) were associated with an ARO infection. Infection prevention and control additional precautions were in place for 13.7% (n=500) of patients, of which half (51.0%, n=255) were due to an ARO. Approximately one third (35.2%, n=1,281) of patients had at least one antimicrobial prescribed. Antimicrobial-resistant organisms remain a serious threat to public health in Canada. The results of this survey warrant further investigation into AROs in smaller Canadian hospitals as a potential reservoir of antimicrobial resistance.

Sections du résumé

Background UNASSIGNED
The availability of national data on the prevalence of antimicrobial resistant infections in smaller, community, northern and rural acute care hospitals is limited. The objective of this article is to determine the prevalence of infections caused by selected antimicrobial-resistant organisms (AROs) in these smaller hospitals.
Methods UNASSIGNED
A point prevalence survey was conducted by 55 hospitals between February and May 2019 and included representation from all 10 Canadian provinces. Eligible hospitals were those with 350 or fewer beds. Data were collected on hospital characteristics. De-identified patient data were collected on selected infections (pneumonia, urinary tract infections, bloodstream infections, skin/soft tissue infections, surgical site infections, and
Results UNASSIGNED
A total of 3,640 patients were included in the survey. Median patient age was 73 years, and 52.8% (n=1,925) were female. Selected infections were reported in 14.4% (n=524) of patients, of which 6.9% (n=36) were associated with an ARO infection. Infection prevention and control additional precautions were in place for 13.7% (n=500) of patients, of which half (51.0%, n=255) were due to an ARO. Approximately one third (35.2%, n=1,281) of patients had at least one antimicrobial prescribed.
Conclusion UNASSIGNED
Antimicrobial-resistant organisms remain a serious threat to public health in Canada. The results of this survey warrant further investigation into AROs in smaller Canadian hospitals as a potential reservoir of antimicrobial resistance.

Identifiants

pubmed: 38222826
doi: 10.14745/ccdr.v48i1112a09
pii: 48111209
pmc: PMC10786237
doi:

Types de publication

Journal Article

Langues

eng

Pagination

559-570

Déclaration de conflit d'intérêts

Competing interests None.

Auteurs

Shari Thomas (S)

Antimicrobial Resistance Task Force, Public Health Agency of Canada, Ottawa, ON.

Denise Gravel Tropper (DG)

Antimicrobial Resistance Task Force, Public Health Agency of Canada, Ottawa, ON.

Braden Knight (B)

Antimicrobial Resistance Task Force, Public Health Agency of Canada, Ottawa, ON.

Donald Sheppard (D)

Antimicrobial Resistance Task Force, Public Health Agency of Canada, Ottawa, ON.

Tanya Lary (T)

Antimicrobial Resistance Task Force, Public Health Agency of Canada, Ottawa, ON.

Jami Mackenzie (J)

Antimicrobial Resistance Task Force, Public Health Agency of Canada, Ottawa, ON.

Greg German (G)

Unity Health, Toronto, ON.

Charles Frenette (C)

McGill University Health Centre, Montréal, QC.

Kathryn Bush (K)

Alberta Health Services, Calgary, AB.

Jennifer Ellison (J)

Alberta Health Services, Calgary, AB.

Jennifer Happe (J)

Infection Prevention and Control Canada, Calgary, AB.

Jayson Shurgold (J)

Antimicrobial Resistance Task Force, Public Health Agency of Canada, Ottawa, ON.

Classifications MeSH